Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.75
+0.33007.47%
Post-market: 4.840.0859+1.81%19:54 EDT
Volume:897.24K
Turnover:4.22M
Market Cap:324.58M
PE:-2.16
High:4.82
Open:4.38
Low:4.31
Close:4.42
Loading ...

BRIEF-Olema Oncology Announces New Clinical Trial Collaboration And Supply Agreement With Novartis In Frontline Metastatic Breast Cancer As Well As $250 Million Equity Private Placement

Reuters
·
02 Dec 2024

Press Release: Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement

Dow Jones
·
02 Dec 2024

Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement

THOMSON REUTERS
·
02 Dec 2024

Olema Pharmaceuticals Inc - Well Capitalized to Fund Operations Beyond Key Milestones

THOMSON REUTERS
·
02 Dec 2024

Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium

GlobeNewswire
·
26 Nov 2024

Press Release: Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Dow Jones
·
25 Nov 2024

Optimistic Buy Rating for Olema Pharmaceuticals Driven by Promising Developments with Palazestrant and Novartis Collaboration

TIPRANKS
·
22 Nov 2024

J.P. Morgan Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
21 Nov 2024

U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Reuters
·
20 Nov 2024

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

TD Cowen Sticks to Its Buy Rating for Olema Pharmaceuticals (OLMA)

TIPRANKS
·
13 Nov 2024

Olema Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Olema Pharmaceuticals Q3 EPS $(0.60) Misses $(0.57) Estimate

Benzinga
·
13 Nov 2024

Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
13 Nov 2024

Olema Pharmaceuticals Inc expected to post a loss of 58 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

Olema Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
06 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Nov 2024

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Nov 2024

Promising Potential of Olema Pharmaceuticals’ Palazestrant and KAT6 Inhibitor Fuels Buy Rating

TIPRANKS
·
24 Oct 2024

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
24 Oct 2024